Details of the Drug

General Information of Drug (ID: DMUOFM4)

• Drug Name: Sernivo
• Synonyms: Diprosone; Diprolene; Diprolene AF; Maxivate; Diproderm; Diprosis; Alphatrex; Psorion; 5593-20-4; Rinderon DP; Betamethasone-17,21-dipropionate; Betamethasone 17,21-dipropionate; Sch-11460; Sch 11460; UNII-826Y60901U; beta-Methasone 17,21-dipropionate; EINECS 227-005-2; S-3440; BRN 3638108; CHEBI:31276; CIWBQSYVNNPZIQ-XYWKZLDCSA-N; S 3440; 826Y60901U; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-dien

Indication

Disease Entry	ICD 11	Status	REF
Plaque psoriasis	EA90.0	Phase 3	[1]

• Chemical Identifiers:
  Formula: C28H37FO7
  Canonical SMILES: CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC
  InChI: InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1
  InChIKey: CIWBQSYVNNPZIQ-XYWKZLDCSA-N
• Cross-matching ID:
  PubChem CID: 21800
  ChEBI ID: CHEMBL31276
  CAS Number: 5593-20-4
  TTD ID: D0MD6C
• Drug Pharmacogenomic Perturbation (DPP)NEW: Click to Jump to the Detailed DPP Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)